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a  b  s  t  r  a  c  t
Recent  research  has begun  to  elucidate  the neural  basis  of  higher  order  social  concepts,  such  as  the
mechanisms  involved  in  intergroup  relations,  and  moral  judgments.  Most  theories  have  concentrated
on  higher  order  emotions,  such  as  guilt,  shame,  or empathy,  as  core  mechanisms.  Accordingly,  psy-
chopharmacological  and  neurobiological  studies  have  investigated  the effects  of manipulating  serotonin
or  oxytocin  activity  on moral  and  social  decisions  and  attitudes.  However,  recently  it  has  been  deter-
mined  that  changes  in more  basic  emotions,  such  as  fear  and  anger,  might  also  have  a signiﬁcant  role
in social  and  moral  cognition.  This article  summarizes  psychopharmacological  and  fMRI  research  on  the
role  of  noradrenaline  in  higher  order  social  cognition  suggesting  that  indeed  noradrenergic  mediated
affective  changes  might  play  key  – and  probably  causal  –  role  in certain  social  attitudes  and  moral  judg-
ments.  Social  judgments  may  also  be  directly  inﬂuenced  by numerous  neurotransmitter  manipulations
but  these  effects  could  be  mediated  by modulation  of  basic  emotions  which  appear  to  play  an  essential
role  in the  formation  of  social  concepts  and  moral  behaviour.
©  2016  The  Authors.  Published  by Elsevier  Ltd. This  is an open  access  article  under  the  CC BY  license
(http://creativecommons.org/licenses/by/4.0/).
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. Introduction
“The lower levels in the neural ediﬁce of reason are the same ones
hat regulate the processing of emotions and feelings, along with the
ody functions necessary for an organism’s survival. In turn, these
ower levels maintain direct and mutual relationships with virtu-
Emotion, feeling and biological regulation all play a role in human
reason.”(Damasio, 1994; p. Xvii).
There has been a long history of research, demonstrating that
basic emotions, such as anger, fear, and happiness, can have an
effect on reasoning (Pham, 2007), including working memory
capacity (i.e., Darke, 1988), categorisation of stimuli (Ibsen et al.,
1992), problem-solving (Isen et al., 1987), self-control (Fry, 1975)lly every bodily organ, thus placing the body directly within the
hain of operations that generate the highest reaches of reasoning,
ecision making, and, by extension, social behaviour and creativity.
∗ Corresponding author.
E-mail address: sylvia.terbeck@plymouth.ac.uk (S. Terbeck).
ttp://dx.doi.org/10.1016/j.neubiorev.2016.03.031
149-7634/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article uand risk taking behaviour (Johnson and Tversky, 1983). But basic
emotions may also inﬂuence attitudes towards other races and
decisions about what is morally right and wrong. Indeed, Nora-
drenaline (NA) based automatic emotional arousal may  play a
key role in the neurobiology of higher order psychological pro-
cesses. Findings following this line of research might be understood
within the framework of the somatic marker hypothesis (Levy
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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t al., 2014), according to which somatic states inﬂuence – and
ften positively aid – explicit responses, and decisions (Damasio,
994). For example noradrenergic beta receptors in the limbic
rain are highly associated with emotional learning and emotion
rocessing (Pitman and Delahanty, 2005), and key brain limbic
egions proposed to mediate somatic markers (Bechara et al., 2005)
ight contribute to moral and social judgments. However, recent
esearch in moral and social psychology has mostly focused on
econdary emotions – social emotions – such as guilt and empa-
hy. It has been stated that secondary emotions, particularly moral
motions differ from primary emotions in that they are often
inked to the welfare of society or other individuals (Haidt, 2003).
oll (2008) suggested that moral emotions typically include guilt,
ity, embarrassment, shame, pride, awe, contempt, indignation,
nd gratitude. It has been argued that moral emotions might be
licited in response to violations of social norms and stereotypes
hat code for individual attitudes and beliefs (Nichols, 2003). In his
eview, Pham (2007) concluded that secondary emotions (such as
uilt, shame, gratitude) have a function in promoting socially and
orally desirable behaviour. Further, Eisenberg (2000) suggested
hat moral emotions play a crucial role in helping people to evaluate
oral features, motivate moral behaviour, and suppress immoral
cts. However, primary emotions, and speciﬁcally noradrenergic
ediated automatic emotional arousal, linked to fear and anger
ight have an equal contribution, and be a core factor, for social
nd moral decisions. This article will review recent research on
he effect of noradrenaline on moral and social decisions. We  will
escribe the role of noradrenaline in higher order social processes,
nd discuss how such ﬁndings could contribute to a more complete
eural model of moral and social judgments.
. Biochemistry of noradrenaline
Early research demonstrated that fearful stimuli elicit the “ﬂight
r ﬁght” response in animals and humans; a response which is
aused by sympathetic nervous system activation (Weiss, 1971),
nd which is mediated by adrenaline and noradrenaline (NA)
elease (Ax, 1953). NA belongs to the chemical class of cate-
holamines and is synthesised from the amino acid precursor
henylalanine and tyrosine. In the brainstem noradrenergic neu-
ons, which mainly function to control blood pressure and ﬂexor
uscles, populate the medulla oblongata and the dorsal vagal
ucleus with projections to the spinal cord (Leonard, 2003). A high
ensity of noradrenergic cells bodies can also be found in the locus
oeruleus which innervates the thalamus, dorsal hypothalamus,
ippocampus and cortex. The ventral noradrenergic bundle, caudal
o the locus coeruleus, is connected to subcortical limbic regions.
eripherally, noradrenaline is part of the sympathetic nervous sys-
em, mediating physiological responses of stress and acute anxiety,
uch as dilatation of pupils and bronchioles, increased heart rate,
onstricted blood vessels, increased kidney renin secretion, and
nhibited peristalsis.
In the face of a threat (either real or perceived) behavioural
daptations to maintain homeostasis are activated with the NA sys-
em being the most prominent modulator (Morilak et al., 2005).
umerous studies in animals, but also in humans have shown
ctivation of NA in response to stressful stimuli such as immobili-
ation, loud noise, immune challenge, electric shock, hypotension,
r cold exposure (see Morilak et al., 2005 for a review). For exam-
le, early studies on experimental animals have found that various
tressors (e.g., extreme temperatures, foot shock) signiﬁcantly
nd selectively reduced brain NA concentration, whilst dopamine
nd serotonin levels seemed to be unaffected (e.g. Bliss et al.,
968; Corrodi et al., 1968). For example, exposure to inescapable
hock/stress led to reduced central noradrenaline (Weiss, 1971).havioral Reviews 66 (2016) 54–60 55
Additionally, Galvin (1985) found that acute stressors elevated
MHPG-SO4 (a metabolite of NA) levels in limbic regions. This net
increase was  also correlated with plasma cortisol elevation. Thus,
in his early review, Galvin (1985) concluded that the evidence
supported the notion that central noradrenaline is involved in
stress responses, stress pathology, and consequences of stress
exposure. More recently, Morilak et al. (2005) reviewed their stud-
ies on animal responses to acute stress. They found that stress
activated NA release in a number of brain regions including the cen-
tral and medial amygdala, lateral bed nucleus of the stria terminalis,
medial prefrontal cortex, and lateral septum. Using microinjec-
tions in those regions to administer NA antagonistic drugs they
determined NA-mediation of a number of stress related behaviours
in rats, such as activation of defensive burying and reduction of
social interaction. The authors argue that neurobiological changes
in those regions might contribute to psychiatric disorders such as
anxiety, post-traumatic stress disorder (PTSD), or depression.
Levels of NA activity can be manipulated (i.e., reduced or
enhanced) with various psychotropic drugs acting on adrenore-
ceptors. Adrenoreceptors (in - and  form) are metabotropic
G-protein-coupled receptors. Within the beta receptors 1, 2, and
3, subtypes can be determined. For example, propranolol, a cen-
trally and peripherally acting beta receptor antagonist of both 1
and 2 receptors was originally developed for hypertension, but
due to its inhibitory effect on emotional arousal also is a widely used
treatment for stress, acute anxiety, and performance anxiety (e.g.,
Tyrer and Lader, 1974). Additionally, recent research has suggested
that, by reducing the consolidation of emotional memory, propra-
nolol might also be effective in preventing the development of
PTSD, whether by being administered before exposure to a poten-
tially traumatic situation or immediately afterwards (Mills and
Dimsdale, 1991; Pitman and Delahanty, 2005; Stein et al., 2007).
Buffalari and Grace (2007) researched the effect of propranolol
on the basolateral amygdala using single unit neuronal record-
ings in rats. The authors found that NA enhances tonic excitatory
effects via beta receptors in the basolateral amygdala, whilst beta
adrenergic blockade lead to a decrease in spontaneous ﬁring rate.
Several studies have shown that single doses of propranolol also
inﬂuence emotional processing in humans (Hurlemann et al., 2010;
Van Stegeren et al., 2005) and that propranolol reduces physi-
ological markers of high arousal (heart rate, potentiated startle
response) following emotion-evoking stimuli (Mills and Dimsdale,
1991; Davis et al., 1993). In addition, functional neuroimaging stud-
ies have shown that propranolol leads to a reduction in amygdala
responses to emotional pictures or emotional facial expressions
(Hurlemann et al., 2010; Van Stegeren et al., 2005).
In contrast, reboxetine is an example of a selective nora-
drenaline re-uptake blocker. This drug is used as antidepressant
medication and increases synaptic levels of NA by blocking the re-
uptake of NA back into the presynaptic terminal, thereby indirectly
activating both postsynaptic alpha and beta receptors. Therefore,
in terms of the receptors whose actions are inﬂuenced, reboxetine
will have a broader spectrum of action than propranolol (Leonard,
2003). Single doses of reboxetine in healthy volunteers have been
shown to produce a positive bias in implicit emotional processing
in terms of facial expression recognition and emotional memory
(e.g. Harmer et al., 2004; Norbury et al., 2008). Acute reboxetine
administration increases heart rate, presumably through stimula-
tion of cardiac 1 receptors (Leonard, 2003). It is therefore likely
that reboxetine will increase basic emotional arousal.
Previous research has also given evidence for NA being involved
in social behaviour, Vanderschuren et al. (1997) reviewed the neu-
robiology of social play in rats. The authors discussed that whilst
dopamine and opioids were involved in the reward aspect of social
play, noradrenergic systems were also involved in the attentional
processes relevant to social play behaviour. Vanderschuren et al.
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1997) argue that social play in animals might have the function
f establishing social organisation within groups and to inhibit
ggression and increase group stability. Previous studies have
ound that amphetamine, which stimulates catecholamine release,
epressed social play (e.g., Beatty et al., 1984), but increased social
nvestigation (Beatty et al., 1982). Propranolol administration also
ecreased social play (Beatty et al., 1984), although Vanderschuren
t al. (1997) argued that the role of noradrenaline in social play
as still not understood and that the effects seen might depend
n the particular NA receptors (i.e., alpha 1 versus alpha 2 versus
eta receptors) targeted. More recently, Achterberg et al. (2016)
nvestigated the differential effect of dopamine and NA in social
lay in rats, determining that dopamine was more strongly associ-
ted with motivation for play whilst NA enhancement negatively
odulated both motivation as well as expression of social play.
urthermore, Achterberg et al. (2015) determined that infusion
f methylphenidate and atomoxetine into prefrontal and limbic
rain areas inhibited social play (via increased NA activity), but
ot social exploratory behaviour, further supporting the modu-
atory role of NA in the development of social play behaviour.
anderschuren et al. (2008) also found that methylphenidate abol-
shed social play in rats. As methylphenidate and atomoxetine are
rst-choice treatment for attention-deﬁcit/hyperactivity disorder
ADHD) in children, such effects are potentially important in social
evelopment and are worthy of careful assessment in clinical stud-
es.
. Noradrenaline and intergroup attitudes
Research on prejudice and stereotypes started in the 1920s and
930s, a time when there was overt racial conﬂict and legally sanc-
ioned racial discrimination in the United States. However, biases
ontinue to operate in contemporary society, especially on mea-
ures of implicit attitude (i.e., Greenwald et al., 1998). Compared
o explicit prejudice and stereotypes about out-group members,
ndividuals also display implicit associations towards out-group
embers that might be automatic and occur even with a sincere
xplicit belief in equality (Nosek et al., 2007; Terbeck et al., 2012a).
ndeed correlations between explicit and implicit out-group evalu-
tions are found to be usually weak (∼r < 0.15) (Nosek et al., 2007),
hich suggest that they may  have distinct underlying neurobiolog-
cal mechanisms (De Houwer et al., 2009).
The implicit association test (IAT) (Greenwald et al., 1998) is
 widely used method to assess implicit attitudes (Nosek et al.,
007). In this item-sorting, response time based task, partici-
ants perform a categorisation task by sorting positive/negative
ords and pictures of faces from black/white individuals. The IAT
ffect is determined by latency differences in response times to
ias congruent (good white/bad black) versus incongruent (good
lack/bad white) trials. Extensive evidence shows that the IAT can
e regarded as a reliable measure of implicit attitudes towards
ocial out-groups, whether based on race, sexual orientation, gen-
er, or political preference (Nosek et al., 2007). A meta–analysis
urther suggested that the IAT is a better predictor of some forms of
iscrimination against out-group members than explicit measures
Poehlman et al., 2004). Several studies, speciﬁcally fMRI stud-
es have suggested that, implicit “prejudice” involves a stronger
motional component than explicit prejudice (Lieberman, 2005;
heeler and Fiske, 2005).
One of the earliest neuroscientiﬁc investigations of racial atti-
udes was conducted by Phelps et al. (2000). These researchers
sed fMRI to assess the blood-oxygen-level-dependent (BOLD)
esponses in association with white, compared to black, unfamil-
ar male faces (participants were white Americans). Outside the
canner, they also assessed racial attitudes of the participants usinghavioral Reviews 66 (2016) 54–60
implicit and explicit measures. Importantly, the authors found that
the magnitude of the BOLD response to black versus white faces
in the amygdala was signiﬁcantly correlated with the implicit, but
not the explicit, measure of racial bias. Subsequent research has
demonstrated that other brain areas, including the dorsolateral
prefrontal cortex (dlPFC) and the anterior cingulate cortex (ACC)
might contribute to mechanisms reviewing the initial evaluation
(Cunningham et al., 2004; Knutson et al., 2007; Richeson et al.,
2003; Stanley et al., 2008).
Recently, our own research conﬁrmed previous theorizing on
the role of primary emotions, in implicit racial attitudes (Terbeck
et al., 2012a,b). In this psychopharmacological study, healthy vol-
unteers of white ethnic origin, received a single oral dose of the
propranolol (40 mg). Participants completed an explicit measure
of prejudice and the racial IAT 1–2 h after propranolol adminis-
tration. Importantly, relative to placebo, propranolol reduced the
implicit racial bias, without affecting the explicit racial preju-
dice measure. These results indicate that -adrenoceptors play a
role in the expression of implicit racial attitudes suggesting that
noradrenaline related emotional mechanisms may  mediate racial
biases. Furthermore, using fMRI following the same pharmacologi-
cal manipulation, we  found support for the suggestion that central
automatic emotional arousal might be causally involved in implicit
racial biases (Terbeck et al., 2015). In this study 40 participants also
received propranolol or placebo in a double blind manner. Par-
ticipants then viewed unfamiliar black or white faces during the
fMRI scan and subsequently completed the racial implicit associ-
ation test. Propranolol reduced the IAT score and led to reduced
activity for black compared to white faces in fusiform gyrus (See
Fig. 1). Furthermore, time course analysis of the fusiform gyrus
activity demonstrated that sensitization to the viewing of black
faces, which was observed with placebo, was  diminished with pro-
pranolol. We suggested that the racial face perception at early
stages was  thus modulated by basic noradrenergic activity. Indeed,
our research supports previous accounts suggesting that face pro-
cessing areas (i.e., fusiform gyrus) might mediate the processing of
ingroup versus outgroup faces (e.g., Golby et al., 2001).
In conclusion, most neuroscience studies, fMRI research
(Cunningham et al., 2004; Knutson et al., 2007; Richeson et al.,
2003; Terbeck et al., 2012b) and recent psychopharmacological
studies (Terbeck et al., 2012b) have supported the theory that basic
emotional arousal, such as fear or aggression, possibly mediated
by noradrenergic activation, might be causally relevant for implicit
social attitudes.
4. Noradrenaline and moral judgment
The earliest investigations of morality can be found in Plato’s
approaches over 2000 years ago (Casebeer and Churchland, 2003).
Casebeer and Churchland, (2003) deﬁned moral reasoning as “. . .
a series of acts that result in a conclusion about what one ought
to do or think”. To research human moral decision-making, most
researchers use theoretical moral judgments, such as the trolley
dilemma: You are at the wheel of a runaway trolley quickly approach-
ing a fork in the tracks. On the tracks extending to the left is a group of
ﬁve railway workmen. On the tracks extending to the right is a single
railway workman. If you do nothing, the trolley will proceed to the
left, causing the deaths of the ﬁve workmen. The only way to avoid the
deaths of these workmen is to hit a switch on your dashboard that will
cause the trolley to proceed to the right, causing the death of the single
workman. How morally acceptable is it to hit the switch in order to
avoid the deaths of the ﬁve workmen?
This dilemma involves harming one as a side-effect of saving
ﬁve. In contrast, the second “up close and personal” version involves
pushing a person in front of the trolley as a means to stopping it
S. Terbeck et al. / Neuroscience and Biobehavioral Reviews 66 (2016) 54–60 57
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sFig. 1. Chronological representation of the ev
illing 5 people further down the track. This harm is sacriﬁcial and
nvolves using the person killed as a means to saving the ﬁve. Typi-
ally people switch in the ﬁrst “impersonal” version to save the ﬁve,
ut refuse to kill the one in the second to save the ﬁve. According
o emotivists, moral decisions are expressions of pro or con atti-
udes. Also sentimentalism supports the idea that emotion plays a
entral, causal role in moral judgments (Nichols and Mallon, 2005).
or example, Gibbard, (1990) argued that feeling guilty about an
ction is the central emotional response in guiding moral choice.
Previous research has already suggested that there might be
ssociations between primary emotional arousal and moral judg-
ents. For example, Carlson and Miller (1987) found that positive
ood enhanced pro-social behaviour. And Scher (1997) demon-
trated that anger and sadness were linked to perceptions of
njustice and immorality. In addition Wheatly and Haidt (2005)
ound that subjects, who were hypnotized to feel disgust, made
ore severe moral judgments. Haidt and Bjorklund (2008) sug-
ested that moral decisions are the product of quick and automatic
ntuitions, whilst conscious reasoning on the other hand occurred
s a post-hoc justiﬁcation of already preferred options chosen by
ntuition. Furthermore, Moretto et al. (2010) found that healthy
ndividuals, but not patients with ventromedial prefrontal cortex
vmPFC) damage, generated skin conductance responses (a somatic
arker of affective arousal), before making judgments in personal
ilemmas. This anticipatory skin conductance response was  neg-
tively correlated with the frequency of utilitarian judgments in
ealthy individuals, suggesting involvement of somatic emotional
rousal in moral decision-making, that is the greater the affective
esponse the less the chance of making a utilitarian judgment.
We recently investigated the role of noradrenergic transmission
n moral decision-making (Terbeck et al., 2013). In a double-blind
tudy 40 participants received propranolol or placebo before judg-
ng moral acceptability in theoretical moral dilemmas. We  found
hat propranolol made participants more likely to judge sacriﬁcial
ctions as morally unacceptable. Additionally, we only found this
ffect in dilemmas where harms were ‘up close and personal’ (i.e.,
hose involving more active and direct harmful action). Previously,
reene et al. (2001) suggested that deontological moral judgments
e.g., judgments that determine the moral worth of action or rules,
egardless of the consequences) are driven by emotion, whilst util-
tarian judgments (i.e., judgments of morality that are determined
y the resulting outcome) are caused by cognitive processes over-
iding initial emotional judgments. Additionally, Greene (2008)
uggested that emotional and cognitive processes compete, lead-n of the knowledge of Noradrenaline effects.
ing to conﬂict (as reﬂected by for example activation of the anterior
cingulate cortex).
Our results with propranolol, however, (Terbeck et al., 2013)
are contrary to this theory, suggesting that general physiological
arousal (at least that associated with NA activation) is not likely
to play a causal role in deontological judgments. We  suggested
however that propranolol administration might have led to an
increase in aversion to harming others directly (that is, in sacriﬁ-
cial moral dilemmas). Indeed, this is in line with extensive evidence
that propranolol reduces aggression (Greendyke et al., 1986; Silver
et al., 1999), supporting the idea that basic emotions − such as
harm aversion and aggression − might contribute to such moral
choices. Furthermore, other pharmaceuticals, such as atomoxetine
(general cognitive enhancers), commonly used to treat attention
deﬁcit hyperactivity disorder, might have stronger effect on aggres-
sion and harmful social behaviour by reducing impulsivity, and thus
increasing self-control of anger and fear responses (Crockett, 2014).
5. Noradrenaline in higher order social concepts:
comparing the effect
In the previous sections we  have discussed research on the
involvement of NA in higher order social and moral judgments.
Indeed the knowledge of the effect of NA  has greatly advanced
over the last decade. Fig. 2 gives an overview of the evolution of
knowledge of NA and its effects on human behaviour.
However the action of NA cannot be viewed in isolation; instead
its interactions with other neurotransmitters need to be consid-
ered. In the following, we will describe the activity of two  other
key neurotransmitters − namely serotonin and oxytocin − which
have also been shown to inﬂuence social behaviour in humans.
We will then describe possible interaction mechanisms of these
different neurotransmitter systems. Serotonin levels are increased
with selective serotonin reuptake inhibitors (SSRIs), which are
commonly prescribed for the treatment of depression and a wide
range of anxiety disorders. SSRIs block the re-uptake of serotonin
in the presynaptic nerve terminal thereby increasing its activity
at the synapse and indirectly stimulating all post-synaptic sero-
tonin receptor subtypes. In some patients, SSRIs alleviate depressed
mood and reduce excessive anxiety, which has been suggested to be
the result of increasing cognitive control over basic limbic processes
(Levy et al., 2014). Similar to effects observed with propranolol,
SSRIs have also been shown to affect moral behaviour. For example,
participants taking SSRIs were more cooperative and less critical
58 S. Terbeck et al. / Neuroscience and Biobehavioral Reviews 66 (2016) 54–60
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tig. 2. Whole Brain image under placebo versus propranolol to black versus white
o  black versus white faces. Image thresholded at Z = 2.3, p > 0.05, corrected. Images
ource: from Terbeck et al. (2015).
Knutson et al., 2007) and more socially afﬁliative towards others
Tse and Bond, 2002). Furthermore, Crockett et al. (2010) found
hat tryptophan depletion (which reduces net brain serotonin con-
entration) led to increased rates of rejection of unfair offers. More
ecent work has suggested that potentiating serotonin increased
eontological moral judgment, which the authors explained as
n effect of increased aversion to causing direct harm to others
Crockett et al., 2010). Interestingly, further analysis revealed that
his effect was driven by an increase in harm aversion only in sub-
ects who were already highly empathetic prior to administration
f the drug (Levy et al., 2014).
Another neurotransmitter that has been suggested to have effect
n levels of empathy, bonding, and love is the hormone and neuro-
ransmitter, oxytocin. Oxytocin facilitates birth and breastfeeding
n humans, but also moral behaviour and intergroup relations.
umerous research studies in humans and animals have suggested
hat oxytocin mediates pair bonding, maternal care, and general
ro-social behaviour (e.g., Insel and Fernald, 2004). For instance
osfeld et al. (2005) found that the administration of oxytocin
ed to more trusting behaviour in humans, that is, investigators
ntrusted the trustee with a signiﬁcantly greater amount of money
Kosfeld et al., 2005). De Dreu et al. (2010) were the ﬁrst to examine
he effects of oxytocin on moral behaviour and intergroup rela-
ions. In a series of moral dilemmas, the authors found that with
lacebo, the race of a person who would be directly harmed to save
any others did not have a signiﬁcant effect on the moral decision.
owever, in the oxytocin group, race did play a role in the moral
ecisions, making subjects more averse to harming one individ-
al to save the lives of others. Speciﬁcally, the authors found that
articipants administered oxytocin were signiﬁcantly more likely
o sacriﬁce a different-race individual in order to save a group of
ace-unspeciﬁed others than they were to sacriﬁce a same-race
ndividual in the same circumstances. Further research by De Dreu
t al. (2010) also suggested that oxytocin might promote empa-
hy in pro-social behaviour but maybe only for in-group members,
educing pro-social behaviour towards the out-group.
The above demonstrates that in addition to noradrenaline,
ther neurotransmitters can also have an effect on moral deci-
ions and intergroup relations. As demonstrated above, different
harmaceutical interventions, with different effects on experi-
nce, can produce seemingly similar changes to moral behaviour.
or instance, while Crockett et al. (2010) found that reduction
f serotonin activity increases in deontological moral decisions
unwillingness to sacriﬁce one to save ﬁve), we found that reduc-
ion in noradrenaline transmission (Terbeck et al., 2013) produced
he same effect. It is indeed difﬁcult to determine if both effects are Whole brain image depicting greater activation under placebo versus propranolol
 radiological format (right brain on left).
mediated by similar neural mechanisms, but recent pharmacolog-
ical fMRI supports the view that different neural circuitry may  be
involved (Terbeck et al., 2015). For example, in our fMRI study of
other race faces we found that noradrenaline particularly affected
neural activity in the thalamus and fusiform gyrus, suggesting that
noradrenaline might be involved in processes mediating the ini-
tial perception and evaluation of emotional stimuli. Furthermore,
NA is suggested to affect basic primary emotional arousal such as
fear and aggression within the limbic system (Leonard, 2003). On
the other hand, the effect of oxytocin on social/afﬁliative responses
has been suggested to involve systems in the ACC, insula, and amy-
dgala (e.g., De Dreu et al., 2010; Insel and Fernald, 2004; Kosfeld
et al., 2005). Serotonin effects might be mostly involed in cogni-
tive control over limbic processes, suggested to play a key role in
controlling mechanisms of basic emotional arousal giving rise to
secondary emotions, such as guilt and shame (for a review see for
example Adolphs, 2009).
However, NA pathways are widely distributed and the effect of
NA manipulation onmoral and social decision making should also
be viewed in the context of interactions with serotonin and oxy-
tocin neurons. Indeed interactions between NA and serotonin have
long thought to be important in the pathophysiology and treat-
ment of mood disorders (Brunello et al., 2003) For example, chronic
administration of SSRIs increases the density of NA beta1 receptors
in rat brain (Pälvimäki et al., 1994). Also, SSRIs have been shown
to lead to long term adaptive changes in the NA system in humans
(e.g., Szabo et al., 2000).
In their review, Cassel and Jeltsch (1995) argued that several
brain regions including the hippocampus, cortex and striatum
might be critical for NA and serotonin interactions. It is well estab-
lished that NA and serotonin can modulate numerous cognitive
processes including learning, memory, sleep, arousal, and anxiety
(Montgomery, 1997; Brunello et al., 2003) It might thus also be sug-
gested that NA affects social behaviour by mediating attentional
processes directly but also by inﬂuencing serotonin pathways
involved in modifying social judgements in cortical regions. NA
might also shape social afﬁliation and intergroup relations via inter-
actions with oxytocin. As stated above, oxytocin is involved in the
regulation of reproductive function, social and sexual behaviours
but also stress responses (Salmina et al., 2010). There is much evi-
dence suggesting an interaction between NA and oxytocin, also
with regards to regulating social behaviour. For example, Salmina
et al. (2010) described evidence suggesting that oxytocin release
was regulated by NA in the hypothalamic-neurophysical system,
speciﬁcally including the supraoptic nucleus and the paraventricu-
lar nucleus (PVN). The authors argued that NA activates presynaptic
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lutamate interneurons closely located around PVN and therewith
ndirectly causes oxytocin release. Furthermore, Onaka et al. (2012)
lso reviewed evidence that oxytocin release was regulated in part
y NA activity, and thereby both neurotransmitters modulated
unctions such as anxiety, energy metabolism and attachment.
tress − such as that occasioned by public speaking − leads to
xytocin release, indicating that oxytocin might have an anxiolytic
ffect (Onaka et al., 2012). Interactions of oxytocin with NA have
lso been located in projections in the medulla oblugata, whilst
imilar interactions in the amydala might be important in the
egulation of social behaviour (Onaka et al., 2012). It could thus be
rgued that NA mediated emotional arousal is involved in implicit
iases though interaction with oxytocin, which promotes in-group
avoritism. Speciﬁcally, basic emotion processing (via NA) might
egulate complementary mechanisms (via oxytocin) that produce
ngroup favoritism and social bonding within one’s own  social
roup.
In conclusion, we have reviewed the inﬂuence of noradrenaline
n higher order psychological processes, suggesting how differ-
nt mechanisms might mediate the effects. We  suggest that fMRI
tudies involving pharmacological manipulation may  elucidate the
ole of different brain regions and neurotranmitter interactions
nvolved in social and moral decisions. Such a combined approach
s a potentially fruitful line of enquiry.
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